Lung transplantation is a highly specialized and generally rare option for treatment for children with end-stage lung disease. Lucile Packard Children’s Hospital Stanford is nationally ranked #10 in Pulmonology by U.S. News & World Report and is one of 17 hospitals in the United States that participates in the International Pediatric Lung Transplant Collaborative (IPLTC). We partner closely with IPLTC to analyze data and then share our learnings and expertise across the U.S. and around the world so that others may benefit.
With one of the best post-operative outcomes for adolescents in the world, our lung transplant team at Lucile Packard Children’s Hospital Stanford has performed more than 25 pediatric double lung transplants since 1989. Our team works closely with experts from our Pulmonary & Cystic Fibrosis Center. Together, we provide treatment for the full range of chronic diseases that may require lung transplantation, from cystic fibrosis to genetic defects.